Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Discovery
Sponsor : LifeArc
Deal Size : $7.2 million
Deal Type : Series A Financing
LifeArc Makes Investment to Support Drug Discovery in Sub-Saharan Africa
Details : This funding will bolster five drug discovery initiatives in Africa, spanning 3-5 years. H3D Foundation's primary focus lies in addressing life-threatening diseases like malaria and tuberculosis.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
January 31, 2024
Lead Product(s) : Undisclosed
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Discovery
Sponsor : LifeArc
Deal Size : $7.2 million
Deal Type : Series A Financing